Skip to main content
. 2017 Jan 6;17:17. doi: 10.1186/s12872-016-0462-5

Table 1.

Summary data (mean and standard deviation or number (%)) and number (%) missing for putative risk factors, by study

AusDiab BMES CUDS Dubbo MCCS NWAHS All Cohorts
Summary Missing Summary Missing Summary Missing Summary Missing Summary Missing Summary Missing Summary Missing
n 7417 3558 894 1747 38897 2316 54829
Age 54.06 (9.49) nil 61.14 (6.91) nil 55.00 (9.72) nil 65.86 (4.3) nil 55.02 (8.61) nil 54.61 (9.77) nil 55.62 (8.94) nil
Women, n (%) 4103 (55) nil 2063 (58) nil 510 (57) nil 987 (57) nil 23430 (60) nil 1241 (54) nil 32582 (59) nil
Systolic blood pressure 130.44 (18.19) 30 (0.4) 142.37 (19.94) 17 (0.48) 132.11 (21.70) nil 144.17 (22.19) nil 136.55 (19.0) 88 (0.23) 130.23 (17.86) 1 (0.04) 136.01 (19.34) 136 (0.25)
Total cholesterol 5.79 (1.05) 1 (0.01) 5.92 (1.05) 442 (12.42) 5.42 (0.98) nil 6.57 (1.23) 4 (0.23) 5.53 (1.06) 148 (0.38) 5.45 (1.03) 17 (0.73) 5.61 (1.08) 612 (1.16)
HDL cholesterol 1.43 (0.39) 2 (0.03) 1.45 (0.43) 445 (12.51) 1.45 (0.39) nil 1.38 (0.38) 7 (0.40) 1.41 (0.40) 33815 (86.93) 1.37 (0.39) 18 (0.72) 1.42 (0.40) 34286 (62.5)
Diabetes, n (%) 458 (6) 1 (0.01) 204 (6) 3 (0.08) 65 (7.3) nil 85 (5) nil 1478 (4) 6 (0.02) 142 (6) nil 2432 (4) 10 (0.02)
FPG (mmol/L) 5.60 (1.22) 1 (0.01) 5.28 (1.50) 342 (9.10) 5.27 (1.50) nil 5.32 (1.68) 11 (0.60) 5.65 (1.10) 12659 (32.5)* 5.40 (1.50) nil 5.70 (1.51) 13013 (23.4)
SEIFA fifth, n (%) 17 (0.22) 6 (0.16) 6 (0.75) nil 128 (0.33) 8 (0.32) 165 (0.30)
1st (most disadvantaged) 625 (8.43) nil 558 (62.42) 1747 (100) 5537 (14.28) 843 (36.40) 9310 (16.98)
2nd 1310 (17.66) 2466 (69.31) 237 (26.51) nil 8023 (20.69) 537 (23.219) 12573 (22.93)
3rd 2151 (29.00) nil 93 (10.40) nil 7149 (18.44) 371 (16.02) 9764 (17.781)
4th 1460 (19.68) 1085 (30.49) nil nil 7978 (20.58) 473 (20.42) 10996 (20.06)
5th (least disadvantaged) 1854 (25.00) 1 (0.03) nil nil 10082 (26.01) 84 (3.63) 12021 (21.92)
Current smoker, n (%) 1050 (14) 131 (1.77) 558 (16) 116 (3.26) 137 (15) nil 309 (18) 18 (1.03) 4378 (11) 10 (0.03) 453 (20) 16 (0.69) 6885 (13) 291 (0.53)
eGFR (ml/min/m2) 94.11 (14.04) 33 (0.44) 66.96 (14.78) 795 (22.34) 87.15 (15.73) nil n/a 1747 (100) n/a 38897 (100) n/a 2316 (100) 86.75 (18.46) 43788 (79.86)
Albumin-creatinine ratio 1.61 (7.22) 37 (0.50) n/a 3558 (100) n/a 894 (100) n/a 1747 (100) n/a 38897 (100) n/a 2316 (100) 1.61 (7.22) 47449 (86.55)
Family history CVD, n (%) n/a 7417 (100) n/a 3558 (100) n/a 894 603 (35) nil 19830 (51) nil 1551 (67) 34 (1.47) 21984 (40) 11903 (27.71)
BMI 27.26 (4.97) 64 (0.86) 26.99 (4.86) 40 (1.22) 28.18 (5.19) 2 (0.22) 26.12 (4.25) 2 (0.11) 26.86 (4.42) 27 (0.07) 28.50 (5.48) 1 (0.04) 26.99 (4.60) 136 (0.25)
High school +, n (%) 2692 (36) 4 (0.05) 2130 (60) 222 (6.24) 211 (24) nil 490 (29) 42 (2.40) 12797 (33) 9 (0.02) 1204 (52) 656 (2.42) 19524 (36) 333 (0.61)
CVD death, n (%) 87 (1.17) nil 246 (6.91) nil 6 (0.67) nil 320 (18.32) nil 691 (1.80) 606 (1.56) 25 (1.08) nil 1375 (2.51) 606 (1.11)
Years of follow-up, mean 11.77 n/a 15.17 n/a 9.82 n/a 18.09 n/a 18.04 n/a 10.46 n/a 16.55 nil

AusDiab Australian Diabetes, Obesity and Lifestyle Study, BMES Blue Mountains Eye Study, CUDS Crossroads Undiagnosed Diabetes Study, MCCS Melbourne Collaborative Cohort Study, NWAHS North West Adelaide Health Study, FPG Fasting plasma glucose, SEIFA Socioeconomic index for areas, eGFR estimated glomerular filtration rate, BMI body mass index

* Participants who did not fast were recorded as missing FPG